top of page

Latest News

December 4, 2023

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting

Poster to be presented Sunday, December 10, 2023

November 15, 2023

K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer

Additional industry veterans recruited to strengthen clinical, translational medicine and preclinical teams.

Nov 8, 2023

K36 Therapeutics Named “Overall BioPharma Startup of the Year” 

Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry

News Archive

Media Contact
info@k36tx.com

bottom of page